Success Metrics

Clinical Success Rate
86.5%

Based on 180 completed trials

Completion Rate
87%(180/208)
Active Trials
18(7%)
Results Posted
49%(88 trials)
Terminated
28(10%)

Phase Distribution

Ph phase_1
15
6%
Ph phase_2
51
19%
Ph early_phase_1
9
3%
Ph phase_4
79
29%
Ph not_applicable
52
19%
Ph phase_3
56
21%

Phase Distribution

24

Early Stage

51

Mid Stage

135

Late Stage

Phase Distribution262 total trials
Early Phase 1First-in-human
9(3.4%)
Phase 1Safety & dosage
15(5.7%)
Phase 2Efficacy & side effects
51(19.5%)
Phase 3Large-scale testing
56(21.4%)
Phase 4Post-market surveillance
79(30.2%)
N/ANon-phased studies
52(19.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.3%

180 of 227 finished

Non-Completion Rate

20.7%

47 ended early

Currently Active

18

trials recruiting

Total Trials

271

all time

Status Distribution
Active(22)
Completed(180)
Terminated(47)
Other(22)

Detailed Status

Completed180
Terminated28
unknown22
Withdrawn19
Recruiting15
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
271
Active
18
Success Rate
86.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 19 (3.4%)
Phase 115 (5.7%)
Phase 251 (19.5%)
Phase 356 (21.4%)
Phase 479 (30.2%)
N/A52 (19.8%)

Trials by Status

recruiting156%
terminated2810%
not_yet_recruiting31%
withdrawn197%
active_not_recruiting31%
unknown228%
completed18066%
enrolling_by_invitation10%

Recent Activity

Clinical Trials (271)

Showing 20 of 271 trialsScroll for more
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT03574792Phase 2

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Completed
NCT03818932Phase 2

Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

Completed
NCT02219373Phase 3

Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study

Not Yet Recruiting
NCT06992427Phase 3

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Recruiting
NCT05063656Phase 4

Biomarker-Driven Pharmacological Treatment of Adolescents With Autism Spectrum Disorder With Gabapentin

Completed
NCT07389551Not Applicable

Comparison of Pregabalin Versus Gabapentin as Pre-emptive Analgesic

Completed
NCT06997016Phase 4

Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients

Enrolling By Invitation
NCT07348952Not Applicable

Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy

Completed
NCT07297888Not Applicable

COMPARISON OF EFFECTS OF GABAPENTIN AND CLONIDINE ON POST-OPERATIVE PAIN AND ANXIETY IN LUMBAR SPINAL SURGERY.

Completed
NCT04025203Phase 4

Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome

Completed
NCT05302999Phase 4

Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Recruiting
NCT05443555Phase 2

Gabapentin to Reduce Alcohol and Improve Viral Load Suppression

Recruiting
NCT04724252Phase 2

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

Recruiting
NCT02466191Phase 4

Treatment of Pendular Nystagmus in OPT

Completed
NCT01744444Phase 2

Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis

Completed
NCT07131527Not Applicable

Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy

Recruiting
NCT02685735Phase 4

Predicting, Understanding and Speeding Recovery After TKA

Terminated
NCT05658887Phase 4

Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery

Completed

Drug Details

Intervention Type
DRUG
Total Trials
271